Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Seminars in Oncology
|
August 1, 1995
Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer
G Giaccone, M Huizing, P E Postmus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size
E van der Wall, D J Richel, M J Holtkamp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group
N van Zandwijk, H J Groen, P E Postmus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
R E Kibbelaar, K E Moolenaar, R J Michalides, et al.
Cancer Treatment Reviews
|
June 1, 1988
Carboplatin in combination therapy for ovarian cancer
W W ten Bokkel Huinink, M E van der Burg, A T van Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up
J G Schrama, I F Faneyte, J H Schornagel, et al.
Anticancer Research
|
September 1, 1996
Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours
J W Baars, M J Holtkamp, W J Nooyen, et al.
Lancet (London, England)
|
August 26, 1998
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement
S Rodenhuis, D J Richel, E van der Wall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2012
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
H J Meulenbeld, E D van Werkhoven, J L L M Coenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study
B Biesma, A N M Wymenga, A Vincent, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Seminars in Oncology
|
August 1, 1995
Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer
G Giaccone, M Huizing, P E Postmus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1994
Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size
E van der Wall, D J Richel, M J Holtkamp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group
N van Zandwijk, H J Groen, P E Postmus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
R E Kibbelaar, K E Moolenaar, R J Michalides, et al.
Cancer Treatment Reviews
|
June 1, 1988
Carboplatin in combination therapy for ovarian cancer
W W ten Bokkel Huinink, M E van der Burg, A T van Oosterom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up
J G Schrama, I F Faneyte, J H Schornagel, et al.
Anticancer Research
|
September 1, 1996
Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours
J W Baars, M J Holtkamp, W J Nooyen, et al.
Lancet (London, England)
|
August 26, 1998
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement
S Rodenhuis, D J Richel, E van der Wall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2012
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
H J Meulenbeld, E D van Werkhoven, J L L M Coenen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2011
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study
B Biesma, A N M Wymenga, A Vincent, et al.
Page
of 8